OBJECTIVE: To identify genetic variation influencing serum bilirubin levels in American Indians, we performed genome-wide screening and association analyses in the Strong Heart Family Study. Bilirubin is an endogenous antioxidant that has demonstrated an inverse relationship with cardiovascular disease. Genetic variation within the promoter region of uridine diphosphate glucuronosyltransferase (UGT1A1) on chromosome 2q has been associated with elevated serum bilirubin levels in European populations. However, no study has investigated the UGT1A1 promoter in American Indians. METHODS: Statistical analyses were carried out with 3,484 participants aged 14 to 93 years recruited from three geographic areas in the United States; Arizona, Oklahoma, and North and South Dakota. RESULTS: Variance components linkage analysis detected a quantitative trait locus (QTL) for bilirubin on chromosome 2q in the combined centers (LOD = 6.61, P = 4.24 × 10⁻⁶) and in Oklahoma (LOD = 5.65, P = 4.57 24 × 10⁻⁵). Genetic association of the UGT1A1 promoter polymorphism was significant for all geographic locations. After adjustment using conditional linkage for UGT1A1 promoter variance, the linkage signal dropped to 1.10 in the combined sample and to 3.32 (P = 0.02) in Oklahoma, indicating this polymorphism is not completely responsible for the linkage signal in American Indians. We also detected suggestive linkage signals in the Dakotas on chromosome 10p12 (LOD = 2.18) and in the combined centers (LOD = 2.24) on chromosome 10q21. CONCLUSIONS: Replication of a serum bilirubin QTL on chromosome 2q in American Indians implicates UGT1A1 but further genotyping is warranted to identify additional causative polymorphisms. Evidence also supports a potential novel locus for bilirubin on chromosome 10.
OBJECTIVE: To identify genetic variation influencing serum bilirubin levels in American Indians, we performed genome-wide screening and association analyses in the Strong Heart Family Study. Bilirubin is an endogenous antioxidant that has demonstrated an inverse relationship with cardiovascular disease. Genetic variation within the promoter region of uridine diphosphate glucuronosyltransferase (UGT1A1) on chromosome 2q has been associated with elevated serum bilirubin levels in European populations. However, no study has investigated the UGT1A1 promoter in American Indians. METHODS: Statistical analyses were carried out with 3,484 participants aged 14 to 93 years recruited from three geographic areas in the United States; Arizona, Oklahoma, and North and South Dakota. RESULTS: Variance components linkage analysis detected a quantitative trait locus (QTL) for bilirubin on chromosome 2q in the combined centers (LOD = 6.61, P = 4.24 × 10⁻⁶) and in Oklahoma (LOD = 5.65, P = 4.57 24 × 10⁻⁵). Genetic association of the UGT1A1 promoter polymorphism was significant for all geographic locations. After adjustment using conditional linkage for UGT1A1 promoter variance, the linkage signal dropped to 1.10 in the combined sample and to 3.32 (P = 0.02) in Oklahoma, indicating this polymorphism is not completely responsible for the linkage signal in American Indians. We also detected suggestive linkage signals in the Dakotas on chromosome 10p12 (LOD = 2.18) and in the combined centers (LOD = 2.24) on chromosome 10q21. CONCLUSIONS: Replication of a serum bilirubin QTL on chromosome 2q in American Indians implicates UGT1A1 but further genotyping is warranted to identify additional causative polymorphisms. Evidence also supports a potential novel locus for bilirubin on chromosome 10.
Authors: Kari E North; Barbara V Howard; Thomas K Welty; Lyle G Best; Elisa T Lee; J L Yeh; Richard R Fabsitz; Mary J Roman; Jean W MacCluer Journal: Am J Epidemiol Date: 2003-02-15 Impact factor: 4.897
Authors: Florian Kronenberg; Hilary Coon; Alexander Gutin; Victor Abkevich; Mark E Samuels; Dennis G Ballinger; Paul N Hopkins; Steven C Hunt Journal: Eur J Hum Genet Date: 2002-09 Impact factor: 4.246
Authors: Andrew D Johnson; Maryam Kavousi; Albert V Smith; Ming-Huei Chen; Abbas Dehghan; Thor Aspelund; Jing-Ping Lin; Cornelia M van Duijn; Tamara B Harris; L Adrienne Cupples; Andre G Uitterlinden; Lenore Launer; Albert Hofman; Fernando Rivadeneira; Bruno Stricker; Qiong Yang; Christopher J O'Donnell; Vilmundur Gudnason; Jacqueline C Witteman Journal: Hum Mol Genet Date: 2009-05-04 Impact factor: 6.150
Authors: Sue Rutherford; Guowen Cai; Juan C Lopez-Alvarenga; Jack W Kent; V Saroja Voruganti; J Michael Proffitt; Joanne E Curran; Mathew P Johnson; Thomas D Dyer; Jeremy B Jowett; Raul A Bastarrachea; Larry D Atwood; Harald H H Goring; Jean W Maccluer; Eric K Moses; John Blangero; Anthony G Comuzzie; Shelley A Cole Journal: Am J Hum Genet Date: 2007-08-20 Impact factor: 11.025
Authors: Jing-Ping Lin; Johannes P Schwaiger; L Adrienne Cupples; Christopher J O'Donnell; Gang Zheng; Veit Schoenborn; Steven C Hunt; Jungnam Joo; Florian Kronenberg Journal: Atherosclerosis Date: 2009-03-19 Impact factor: 5.162
Authors: Suzette J Bielinski; High Seng Chai; Jyotishman Pathak; Jayant A Talwalkar; Paul J Limburg; Rachel E Gullerud; Hugues Sicotte; Eric W Klee; Jason L Ross; Jean-Pierre A Kocher; Iftikhar J Kullo; John A Heit; Gloria M Petersen; Mariza de Andrade; Christopher G Chute Journal: Mayo Clin Proc Date: 2011-06-06 Impact factor: 7.616
Authors: Guanjie Chen; Edward Ramos; Adebowale Adeyemo; Daniel Shriner; Jie Zhou; Ayo P Doumatey; Hanxia Huang; Michael R Erdos; Norman P Gerry; Alan Herbert; Amy R Bentley; Huichun Xu; Bashira A Charles; Michael F Christman; Charles N Rotimi Journal: Eur J Hum Genet Date: 2011-11-16 Impact factor: 4.246
Authors: M C Benton; R A Lea; D Macartney-Coxson; C Bellis; M A Carless; J E Curran; M Hanna; D Eccles; G K Chambers; J Blangero; L R Griffiths Journal: BMC Genet Date: 2015-12-02 Impact factor: 2.797